Profound Total Operating Expenses from 2010 to 2026
| PROF Stock | USD 5.23 -0.08 -1.51% |
Total Operating Expenses | First Reported 2014-03-31 | Previous Quarter 12.7 M | Current Value 11.5 M | Quarterly Volatility 21.4 M |
Financial statement trends for Profound Medical provide structured context on operating performance and capital structure. The series highlights drivers like Depreciation And Amortization of 1.1 M, Interest Expense of 737.9 K or Selling General Administrative of 27.9 M and ratios such as Price To Sales Ratio of 13.75, Dividend Yield of 0.0 or PTB Ratio of 3.8, complementing Profound Medical Valuation and Volatility.
Profound | Total Operating Expenses | Build AI portfolio with Profound Stock |
The Total Operating Expenses trend for Profound Medical Corp offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Profound Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Profound Medical's Total Operating Expenses Growth Pattern
Below is the plot of the Total Operating Expenses of Profound Medical Corp over the last few years. It is the total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses. Profound Medical's Total Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Profound Medical's overall financial position and show how it may be relating to other accounts over time.
| Total Operating Expenses | 10 Years Trend |
|
Total Operating Expenses |
| Timeline |
Profound Total Operating Expenses Regression Statistics
| Arithmetic Mean | 21,145,882 | |
| Geometric Mean | 14,529,456 | |
| Coefficient Of Variation | 80.92 | |
| Mean Deviation | 14,329,868 | |
| Median | 15,509,975 | |
| Standard Deviation | 17,110,296 | |
| Sample Variance | 292.8T | |
| Range | 50.9M | |
| R-Value | 0.95 | |
| Mean Square Error | 30.2T | |
| R-Squared | 0.90 | |
| Slope | 3,220,270 | |
| Total Sum of Squares | 4684.2T |
Profound Total Operating Expenses History
What Is Profound Medical Corp Worth Today?
Profound Medical is a micro-cap equity in Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care categories. Profitability trends drive pricing sustainability. We review the company from a portfolio-construction standpoint emphasizing diversification and stability.
Methodology
Unless otherwise specified, financial data for Profound Medical Corp is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Profound (USA Stocks:PROF) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions Valuation estimates and intrinsic-value models use inputs from public financial disclosures and may not represent market consensus.
Assumptions
We primarily rely on public filings and market reference sources, including disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Data is normalized for analytical consistency across reporting formats. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.Analyst Sources
Profound Medical Corp may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
Currently Active Assets on Macroaxis
More Resources for Profound Stock Analysis
A comprehensive view of Profound Medical Corp starts with financial statements and ratio context. Ratios and trend metrics help frame Profound Medical's operating context. Highlighted below are reports that provide context for Profound Medical Corp Stock:Profound Medical Correlation provides competitor comparison context for Profound Medical. This supports competitive context. Analysis related to Profound Medical should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Earnings Share -1.32 | Revenue Per Share | Quarterly Revenue Growth 0.431 | Return On Assets | Return On Equity |
Understanding Profound Medical Corp includes distinguishing between market value and book value, where book value reflects Profound accounting equity. Intrinsic value is an estimate of what Profound Medical's fundamentals imply, and it may differ from market and book figures. External forces such as sentiment and macro conditions can shift prices away from fundamental signals. Analytical frameworks help compare those viewpoints.
The concept of value for Profound Medical differs from its quoted price, since each reflects a different lens. Evaluation typically reviews profitability, growth, balance sheet strength, industry position, and market signals. Market price reflects the current exchange level formed by active bids and offers.